近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zhang, Lei, Coombes, Jeff, Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, FerrarI, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2016) The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.. Redox Report, 21 1: 14-23. doi:10.1179/1351000215Y.0000000022 Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015) Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 33: 1-10. doi:10.1186/s40697-015-0066-5 Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015) A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 1: 49-57. doi:10.1053/j.ajkd.2014.06.020 Johnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014) Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 1: 23-30. doi:10.1016/S1473-3099(13)70258-5 Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014) Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 1: 23-30. doi:10.1038/ki.2013.391 Navaneethan, SD, Palmer, SC, Smith, A, Johnson, DW and Strippoli, GFM (2010) How to design a randomized controlled trial. Nephrology, 15 8: 732-739. doi:10.1111/j.1440-1797.2010.01428.x Cole, S. R., Smith, A., Wilson, C., Turnbull, D., Esterman, A. and Young, G. P. (2007) An advance notification letter increases participation in colorectal cancer screening. Journal of Medical Screening, 14 2: 73-75. doi:10.1258/096914107781261927 Worthley, Daniel L., Cole, Stephen R., Mehaffey, Sarah, Roosa, Naomi M., Smith, Alicia, Turnbull, Deborah and Young, Graeme P. (2007) Participant satisfaction with fecal occult blood test screening for colorectal cancer. Journal of Gastroenterology & Hepatology, 22 1: 142-143. doi:10.1111/j.1440-1746.2006.04349.x Smith, Alicia, Young, Graeme P., Cole, Stephen R. and Bampton, Peter (2006) Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer, 107 9: 2152-2159. doi:10.1002/cncr.22230 Worthley, Daniel L., Smith, Alicia, Bampton, Peter A., Cole, Stephen R. and Young, Graeme P. (2006) Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. European Journal of Gastroenterology & Hepatology, 18 10: 1079-1083. doi:10.1097/01.meg.0000231754.35340.fa Worthley, D. L., Cole, S. R., Esterman, A., Mehaffey, S., Roosa, N. M., Smith, A., Turnbull, D. and Young, G. P. (2006) Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Internal Medicine Journal, 36 9: 607-610. doi:10.1111/j.1445-5994.2006.01155.x Bampton, P. A., Sandford, J. J., Cole, S. R., Smith, A., Morcom, J., Cadd, B. and Young, G. P. (2005) Interval faecal occult blood testing in a colonoscopy based screening program detects additional pathology. Gut, 54 6: 803-806. doi:10.1136/gut.2004.043786 Smith, Alicia S. and Smid, Scott D. (2005) Imparied capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease. Journal of Gastroenterology and Hepatology, 20 5: 697-704. doi:10.1111/j.1440-1746.2005.03759.x Young, G. P., Bampton, P., Cole, S. R., Morcom, J, Smith, A., Turnbull, D. and Wilson, C. (2004) Screening for colorectal cancer: Update on some current research in Adelaide. South Australian Public Health Bulletin, 1: 22-24.